FOLH1 and neoplasm: To summarize, PSMA PET/CT for CRPC patients demonstrated a considerable utility for its superior detection rate and an important impact on patient management, giving the possibility of a precise and early localization of the tumor sites and to predict the response to systemic or radiotherapy-targeted therapies.